Latest updates for Amgn

Fresh curated links around AMGN are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Amgen's Growth Engine Is Just Getting Started
  • Amgen: A Biotech Giant's Path to Recovery and Growth
  • Argenx

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

seekingalpha.com /1 month ago

Amgen's Growth Engine Is Just Getting Started

Read source
fool.com /1 month ago

Amgen: A Biotech Giant's Path to Recovery and Growth

Join us as we dissect Amgen's stock performance and management strategies. Is this biotech giant poised for growth, or is it facing significant challenges ahead?

Read source
cafepharma.com /1 month ago

Argenx

Argenx Anonymous (not verified) Sun, 06/07/2026 - 17:48 field_thread_url https://cafepharma.com/boards/threads/argenx.665212/ board name...

Read source
cafepharma.com /1 month ago

Argenx

Argenx Anonymous (not verified) Sat, 05/30/2026 - 14:41 field_thread_url https://cafepharma.com/boards/threads/argenx.665212/ board name...

Read source
cafepharma.com /1 month ago

The fall of Amgen

The fall of Amgen Anonymous (not verified) Sun, 05/17/2026 - 08:33 field_thread_url https://cafepharma.com/boards/threads/the-fall-of-amgen.709419/...

Read source
fool.com /1 week ago

How Safe Is Amgen's Dividend?

Near-term headwinds could sink the stock, but there is more to the story.

Read source
cafepharma.com /1 month ago

The fall of Amgen

The fall of Amgen Anonymous (not verified) Sun, 06/07/2026 - 17:48 field_thread_url https://cafepharma.com/boards/threads/the-fall-of-amgen.709419/...

Read source
seekingalpha.com /1 month ago

argenx: The FcRn Franchise Is Becoming An Autoimmune Operating System

Read source
seekingalpha.com /1 day ago

Amyloidosis Continues To Fight Back

Read source
pharmexec.com /3 weeks ago

<![CDATA[Biogen Enters $1 Billion Agreement to Acquire RayThera Inc. ]]>

Read source
cafepharma.com /3 weeks ago

Apellis Acquisition

Apellis Acquisition Anonymous (not verified) Mon, 06/22/2026 - 00:00 field_thread_url https://cafepharma.com/boards/threads/apellis-acquisition.715869/...

Read source
fool.com /1 month ago

A New $21 Million Position Signals Confidence in This Post-IPO Drug Developer

This biotechnology firm leverages machine learning to design novel protein therapeutics targeting unmet medical needs.

Read source
fool.com /1 month ago

Why This Fund Added $12 Million to a Biotech Stock That's Now Down 58% in a Year

ADMA Biologics develops plasma-derived therapies for immune deficiencies and infectious diseases, leveraging a vertically integrated model.

Read source
seekingalpha.com /2 weeks ago

AMUU: Bull 2x Of AMD In The Phase Of Most Extreme Momentum

Read source
cafepharma.com /4 days ago

Apellis Acquisition

Apellis Acquisition Anonymous (not verified) Sat, 07/11/2026 - 09:12 field_thread_url https://cafepharma.com/boards/threads/apellis-acquisition.715869/...

Read source
law360.com /1 week ago

Amgen, Sanofi Team Up To Urge En Banc Antibody IP Review

Rival pharmaceutical companies that squared off at the U.S. Supreme Court over antibody patents have jointly asked the full Federal Circuit to review an unrelated panel decision re...

Read source
cafepharma.com /1 month ago

ANC

ANC Anonymous (not verified) Thu, 06/04/2026 - 17:44 field_thread_url https://cafepharma.com/boards/threads/anc.712901/ board name...

Read source
seekingalpha.com /1 month ago

Agios Pharmaceuticals, Inc. (AGIO) Discusses Global License Agreement for Cevidoplenib and Strategic Expansion in Rare H...

Read source
fool.com /1 month ago

Alumis Stock Has Soared 400%. Cormorant Bought Another $8 Million Last Quarter

Alumis develops clinical-stage therapies targeting autoimmune and neuroinflammatory diseases through proprietary TYK2 inhibitors.

Read source
pharmexec.com /3 weeks ago

<![CDATA[AbbVie to Acquire Apogee Therapeutics in $10 Billion Deal]]>

Read source
seekingalpha.com /1 month ago

Aethlon Medical reports FY results

Read source
cafepharma.com /1 week ago

Genmab

Genmab Anonymous (not verified) Thu, 07/02/2026 - 06:06 field_thread_url https://cafepharma.com/boards/threads/genmab.680642/ board name...

Read source
seekingalpha.com /1 month ago

Ionis Pharmaceuticals: Bull Run Can Continue As Major Catalysts Approach

Read source
cafepharma.com /2 days ago

Genmab

Genmab Anonymous (not verified) Mon, 07/13/2026 - 12:14 field_thread_url https://cafepharma.com/boards/threads/genmab.680642/ board name...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Amgn

seekingalpha.com

Recent coverage from public sources
Public source

cafepharma.com

Recent coverage from public sources
Public source

seekingalpha.com

Recent coverage from public sources
Public source

seekingalpha.com

Recent coverage from public sources
Public source

fool.com

Recent coverage from public sources
Public source

law360.com

Recent coverage from public sources
Public source